IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 213 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $26,240,666 | +10.3% | 2,466,228 | +9.0% | 0.11% | +3.9% |
| Q1 2023 | $23,794,136 | +23.9% | 2,261,800 | +45.9% | 0.10% | +4.1% |
| Q4 2022 | $19,205,045 | +45.8% | 1,550,044 | +21.9% | 0.10% | +6.5% |
| Q3 2022 | $13,172,000 | +22.4% | 1,271,453 | +36.3% | 0.09% | +15.0% |
| Q2 2022 | $10,759,000 | +13872.7% | 933,166 | +13445.7% | 0.08% | +7900.0% |
| Q1 2021 | $77,000 | -28.0% | 6,889 | -26.7% | 0.00% | -50.0% |
| Q4 2020 | $107,000 | +23.0% | 9,395 | -3.4% | 0.00% | 0.0% |
| Q3 2020 | $87,000 | -50.8% | 9,727 | +1.2% | 0.00% | -71.4% |
| Q3 2018 | $177,000 | +302.3% | 9,607 | +227.7% | 0.01% | +133.3% |
| Q4 2017 | $44,000 | – | 2,932 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |